Co-Diagnostics Inc (NASDAQ:CODX)
| 27.62 Delayed Data As of Aug 05 |  -0.76 / -2.68%Today’s Change | 0.85 Today|||52-Week Range 30.99 | +2,985.34% Year-to-Date |
Latest CODX News | Press Releases
| Biotech Bonanza - Second Half Outlook Jul 28 / Seeking Alpha - Paid Partner Content | 3 Best-Performing Coronavirus Stocks of 2020 So Far: Are They Buys Now? Jul 26 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 28.38 |
| Today’s open | 28.03 |
| Day’s range | 27.30 - 28.99 |
| Volume | 2,027,644 |
| Average volume (3 months) | 5,908,288 |
| Market cap | $658.1M |
Data as of 3:59pm ET, 08/05/2020
Growth & Valuation
| Earnings growth (last year) | +26.41% |
| Earnings growth (this year) | +672.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +438.63% |
| P/E ratio | NM |
| Price/Sales | 69.78 |
| Price/Book | 239.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MORFMorphic Holding Inc | +1.36 | +5.89% |
| AUTLAutolus Therapeutics... | +0.34 | +2.31% |
| BCRXBioCryst Pharmaceuti... | -0.02 | -0.47% |
| CARACara Therapeutics In... | -0.03 | -0.17% |
Data as of 4:00pm ET, 08/05/2020
Financials
| Next reporting date | August 12, 2020 |
| EPS forecast (this quarter) | $0.59 |
| Annual revenue (last year) | $215.0K |
| Annual profit (last year) | -$6.2M |
| Net profit margin | -2,882.00% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
